Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
44.7M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
+$31.5M
-
Number of buys
-
42
-
Number of sells
-
-25
-
Price
-
$23.79
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q4 2021
89 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q4 2021.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.7M shares
of 130M outstanding shares and own 34.39% of the company stock.
Largest 10 shareholders include FMR LLC (7.87M shares), JANUS HENDERSON GROUP PLC (4.25M shares), RA CAPITAL MANAGEMENT, L.P. (4.24M shares), TPG GP A, LLC (4.21M shares), Abingworth LLP (4.17M shares), VANGUARD GROUP INC (3.13M shares), BlackRock Inc. (2.78M shares), FRAZIER MANAGEMENT LLC (2.31M shares), Medicxi Ventures Management (Jersey) Ltd (1.89M shares), and STATE STREET CORP (1.17M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.